In summary, while limited by data availability, our RNA transcriptomic and imaging analyses reveal that high PPARγ expression may be broadly associated with improved breast cancer survival, particularly in ER+ and premenopausal patients, which we hypothesize is facilitated through enhanced lipid oxidative metabolism and anti‐inflammatory regulation (across tumor types). The gene discussed is PPARG; the disease is breast carcinoma.